Advisornet Financial’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-100
Closed -$614 1974
2024
Q3
$614 Hold
100
﹤0.01% 2006
2024
Q2
$665 Hold
100
﹤0.01% 1893
2024
Q1
$1.02K Sell
100
-5,989
-98% -$60.9K ﹤0.01% 1759
2023
Q4
$68.5K Hold
6,089
0.01% 732
2023
Q3
$15.8K Hold
6,089
﹤0.01% 1106
2023
Q2
$21.5K Hold
6,089
﹤0.01% 1060
2023
Q1
$25.7K Hold
6,089
﹤0.01% 987
2022
Q4
$100K Hold
6,089
0.01% 623
2022
Q3
$78K Hold
6,089
0.01% 719
2022
Q2
$71K Hold
6,089
0.01% 777
2022
Q1
$37K Sell
6,089
-8,552
-58% -$63K ﹤0.01% 1055
2021
Q4
$134K Sell
14,641
-89
-0.6% -$946 0.01% 699
2021
Q3
$167K Sell
14,730
-8,709
-37% -$106K 0.01% 638
2021
Q2
$231K Buy
23,439
+3,730
+19% +$51K 0.02% 563
2021
Q1
$278K Buy
19,709
+200
+1% +$3.23K 0.02% 467
2020
Q4
$220K Buy
19,509
+10,520
+117% +$124K 0.02% 480
2020
Q3
$119K Buy
8,989
+2,805
+45% +$56.1K 0.01% 628
2020
Q2
$66K Buy
6,184
+1,770
+40% +$9.72K 0.01% 780
2020
Q1
$14K Buy
+4,414
New +$10.2K ﹤0.01% 1161

Other funds holding ALT

Advisornet Financial's ALT Position: Q4 2024 in Review

Advisornet Financial sold out of Altimmune (ALT) in Q4 2024, closing a stake of 100 shares — an estimated $614 sold.

Advisornet Financial first reported a position in ALT in Q1 2020 and held it in 19 quarters. The position peaked at $278K in Q1 2021. 182 funds tracked by Wall St. Rank hold ALT as of Q4 2024.

  • Advisornet Financial reported no remaining Altimmune position as of Q4 2024 after selling out during the quarter.
  • Advisornet Financial sold 100 Altimmune shares in Q4 2024, an estimated $614.
  • Advisornet Financial first reported a position in Altimmune in Q1 2020 and held it in 19 quarters.
  • Advisornet Financial's Altimmune position peaked at $278K in Q1 2021.
  • 182 funds tracked by Wall St. Rank held Altimmune as of Q4 2024.

Based on Advisornet Financial's 13F filing for Q4 2024, filed 13 Jan 2025.